New Novodiag® Carbar+ test allows rapid, cost-effective molecular testing for ‘superbacteria’ and associated drug resistance

Mobidiag Ltd., a commercial stage molecular diagnostics company addressing the spread of antimicrobial resistance, today announces the CE-IVD marking of Novodiag® CarbaR+. Novodiag®CarbaR+ is a single molecular test allowing fully automated detection of Carbapenemase-Producing Enterobacteriaceae (CPE), and associated resistance markers.